secwatch.observer — SEC 8-K summary
======================================

Issuer:     LISATA THERAPEUTICS, INC. (LSTA)
CIK:        0000320017
Form:       8-K
Filed at:   2022-09-29T23:59:59+00:00
Accession:  0000320017-22-000094
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Lisata regains Nasdaq minimum bid price compliance; delisting risk removed
--------------------------------------------------------------------------

- Received Nasdaq deficiency letter on Feb 18, 2022 for bid price below $1.00.
- Granted initial 180-day period ending Aug 17, 2022, then second period to Feb 13, 2023.
- On Sept 29, 2022, notified compliance regained after 10 consecutive days at $1.00+.
- Nasdaq confirmed the matter is now closed.
- Stock ticker LSTA remains listed on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/320017/000032001722000094/0000320017-22-000094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/320017/000032001722000094/clbs-20220929.htm
  HTML page:      https://secwatch.observer/filing/0000320017-22-000094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer